ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 270 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,016,270 | +30.2% | 96,750 | +49.6% | 0.00% | 0.0% |
| Q2 2023 | $1,549,134 | +85.7% | 64,682 | +45.9% | 0.00% | +200.0% |
| Q1 2023 | $834,197 | +38.7% | 44,325 | +17.3% | 0.00% | 0.0% |
| Q4 2022 | $601,553 | -12.2% | 37,786 | -9.7% | 0.00% | 0.0% |
| Q3 2022 | $685,000 | -1.6% | 41,868 | -15.2% | 0.00% | 0.0% |
| Q2 2022 | $696,000 | -53.2% | 49,381 | -19.6% | 0.00% | -50.0% |
| Q1 2022 | $1,487,000 | -22.6% | 61,397 | -25.4% | 0.00% | -33.3% |
| Q4 2021 | $1,920,000 | +11.2% | 82,258 | -20.9% | 0.00% | 0.0% |
| Q3 2021 | $1,727,000 | -18.6% | 104,000 | +19.5% | 0.00% | 0.0% |
| Q2 2021 | $2,122,000 | +8.8% | 87,027 | +15.1% | 0.00% | 0.0% |
| Q1 2021 | $1,951,000 | -14.6% | 75,637 | +77.0% | 0.00% | -25.0% |
| Q4 2020 | $2,284,000 | +88.6% | 42,726 | +45.5% | 0.00% | +33.3% |
| Q3 2020 | $1,211,000 | +52.7% | 29,368 | +79.4% | 0.00% | +50.0% |
| Q2 2020 | $793,000 | +31.1% | 16,366 | +14.4% | 0.00% | 0.0% |
| Q1 2020 | $605,000 | +7.8% | 14,312 | +9.2% | 0.00% | +100.0% |
| Q4 2019 | $561,000 | +155.0% | 13,101 | +124.5% | 0.00% | -75.0% |
| Q3 2017 | $220,000 | – | 5,836 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 432,317 | $11,154,000 | 4.70% |
| Baker Brothers Advisors | 41,910,704 | $1,081,296,000 | 4.69% |
| Palo Alto Investors LP | 2,337,877 | $60,317,000 | 3.44% |
| Birchview Capital, LP | 177,000 | $4,567,000 | 2.71% |
| Longitude (Cayman) Ltd. | 188,000 | $4,850,000 | 1.86% |
| GREAT POINT PARTNERS LLC | 311,217 | $8,029,000 | 1.66% |
| Avoro Capital Advisors LLC | 2,500,000 | $64,500,000 | 1.11% |
| PFM Health Sciences, LP | 1,302,129 | $33,595,000 | 1.03% |
| HealthCor Management, L.P. | 900,490 | $23,233,000 | 0.82% |
| Eversept Partners, LP | 420,000 | $10,836,000 | 0.82% |